Digital contact tracing can slow or even stop coronavirus transmission and ease us out of lockdown

23 April 2020

A team from NDM's Big Data Institute is sharing an epidemiological model to help configure a contact tracing app for coronavirus.

The model offers several safe configurations to introduce an app and a framework to optimise the app after it is released. The simulations confirm that if around half the total population use the app, alongside other interventions, it has the potential to stop the epidemic and help to keep countries out of lockdown. These research efforts are supporting several European projects including the UK’s national programme led by NHSX, a joint unit comprised of teams from NHS England and the Department of Health & Social Care.

National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines

23 April 2021

Data from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance survey, one of the NIHR’s COVID-19 urgent public health studies, is a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC).

CCOUC Webinar on Health-EDRM Education and Research in China: Commemorating the 512 Wenchuan Earthquake

14 April 2021

You are cordially invited to join the CCOUC Webinar on Health-EDRM Education and Research in China: Commemorating the 512 Wenchuan Earthquake. As a commemoration of the 512 Wenchuan Earthquake in 2008, experts will share with you an update on the latest Health-EDRM Education and Research in China. This is a webinar of the CCOUC 10th Anniversary International Webinar Series on Health Emergency and Disaster Risk Management.

Oxford University researchers release cheap, quick COVID-19 antibody test

6 April 2021

The new easy-to-produce test detects coronavirus spike-protein binding antibodies in people who have tested positive for COVID-19.

The RECOVERY Trial: One year on

24 March 2021

Thanks to the ground-breaking work of RECOVERY, clinicians treating patients hospitalised with severe COVID-19 now have two treatments that are known to improve survival. From having no known effective drugs when the pandemic first erupted, patients are now offered treatments that have been robustly proven to reduce death and improve other outcomes, such as the length of hospital stay and the need for mechanical ventilation.

USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective

22 March 2021

A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.

Professor Cecilia Lindgren appointed Director of the Big Data Institute

10 March 2021

Professor Cecilia Lindgren has been appointed as the new Director of the University of Oxford’s Big Data Institute. Professor Lindgren will take up post on 1 April 2021. She succeeds Professor Gil McVean who was the founding director of the BDI, and Interim Director, Professor Martin Landray.